Notice of the 81st Annual General Meeting of the Company.
ABBOTINDIA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Abbott India has called its 81st AGM on August 13, 2025, to be held via video conferencing. The agenda includes adopting audited financial statements for FY25, declaring a final dividend of ₹475 per share (on a ₹10 face value), and re-appointing two non-executive directors retiring by rotation: Ms. Alison Davies and Mr. Kaiyomarz Marfatia. Members will also vote on appointing M/s. BNP & Associates as Secretarial Auditors for a five-year term (FY26 to FY30) and ratifying the ₹0.09 crore remuneration of M/s. Joshi Apte & Associates as Cost Auditors for FY26. A key special business item is the appointment of Mr. Kartik Rajendran as Director and Managing Director for five years from June 14, 2025 to June 13, 2030, with a proposed salary of ₹4.50 crore per annum (ceiling of ₹10 crore), plus performance-linked incentives up to 100% of salary and eligibility for Abbott Laboratories USA stock awards. The dividend record date is July 25, 2025, with payment from August 18, 2025.
Shareholders on record by July 25, 2025 stand to receive the ₹475 final dividend, with e-voting running August 10-12 and a cut-off date of August 6, 2025. The leadership transition to Mr. Kartik Rajendran as MD signals continuity from within the Abbott group, and the substantial dividend reflects strong cash generation for FY25.